Eurofins, FR0014000MR3

Eurofins completes Element acquisition: what it means for Eurofins stock

Published on 10/03/2026 at 10:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eurofins stock costs EUR 75.21 in weekend trading on October 3, 2026 after a Xetra close of EUR 75.21. The company completed two transactions on October 1.

Wissenschaftlerin analysiert Lebensmittelproben mit Pipette im modernen Testlabor
Fotorealistisches Labor mit Pipetten zeigt Eurofins Scientific SE, den Prüfdienstleister mit ISIN FR0014000MR3, bei Probenanalyse, Illustration mit AI erstellt.

Eurofins Scientific SE said on October 2, 2026, that it completed its acquisition of Element Materials Technology’s North American Life Sciences Testing Services business on October 1, 2026, according to an Eurofins release.

Eurofins stock costs EUR 75.21 in weekend trading

At 10:43 a.m. CEST on October 3, 2026, Eurofins stock was at EUR 75.21 in weekend trading at Lang & Schwarz. The price was unchanged at 0.00 percent versus the close of EUR 75.21 at Lang & Schwarz on October 2, 2026. The bid was EUR 75.14 and the ask was EUR 75.28. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of Eurofins stock.

The last Xetra trading day

The close at Lang & Schwarz on October 2, 2026 was EUR 75.21. Xetra and the primary exchanges are closed during the publication window, with the next Xetra session scheduled for October 5, 2026.

Two transactions completed

Eurofins said the Element transaction had an enterprise value of USD 400 million when announced on July 20, 2026. The acquired business operates through 27 laboratories and facilities, employs approximately 750 staff and is expected to generate more than USD 150 million in annual revenue in 2026, according to the company release.

Eurofins also completed the divestment of its Electrical & Electronic Testing business, known as MET Labs, to UL Solutions on October 1, 2026. The transaction had an enterprise value of EUR 575 million on a cash-and-debt-free basis. Eurofins said the proceeds would support priorities including debt reduction, laboratory capital expenditure, digital solutions, robotics and artificial intelligence, share buybacks and strategic acquisitions, according to a separate Eurofins release.

Disclaimer...

en | FR0014000MR3 | EUROFINS | boerse | 70219964 | bgmi